Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81
Organisation › Details

Jellagen Pty. Ltd. (GB)

Jellagen Pty Ltd founded in 2013, is a marine biotechnology Company based in Cardiff, whose strategic mission is to exploit sustainable marine species and natural resources, to develop technical and scientific high value products, meeting state of the art specifications. The first products developed by Jellagen are based on Next Generation Collagen extracted from Jellyfish. The first range of products developed through this new technology, are cell culture reagents used to grow stem cells in 2D and 3D by the Biotech and Pharma Industry R&D teams. The second range of products will be medical devices and biomaterials in the areas of wound and regenerative medicine, also engineered around jellyfish collagen. *


Period Start 2013-01-01 established
Products Industry biomaterials
Person Person Mearns Spragg, Andrew (Jellagen 201805 CEO + Founder before Aquapharm)
Region Region Cardiff
  Country United Kingdom (GB)
  Street Unit G5, Parkway, Wentloog Industrial Estate
Capital Business Park
  City CF3 2PX Cardiff
  Tel +44-333-358-3299
    Address record changed: 2018-05-06
Basic data Employees n. a.
    * Document for �About Section�: Jellagen Pty. Ltd.. (4/27/18). "Press Release: Marine Biotechnologies Firm Jellagen on Course for Accelerated Growth Thanks to £3.8m Funding from Newable Private Investing, Development Bank of Wales and Angel Investors". Cardiff.
Record changed: 2018-09-12


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Jellagen Pty. Ltd. (GB)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioPharm America 2020 Digital Event BEU2020 650x81

» top